NZ511762A
(en)
|
1993-07-19 |
2003-09-26 |
Univ British Columbia |
Anti-angiogenic compositions and methods of use
|
US5886026A
(en)
*
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
US5681846A
(en)
*
|
1995-03-17 |
1997-10-28 |
Board Of Regents, The University Of Texas System |
Extended stability formulations for paclitaxel
|
US6964946B1
(en)
*
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6395770B1
(en)
|
1995-10-26 |
2002-05-28 |
Baker Norton Pharmaceuticals, Inc. |
Method and compositions for administering taxanes orally to human patients
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
CA2240595A1
(en)
*
|
1995-12-21 |
1997-07-03 |
Bijan Almassian |
Taxane composition and method
|
KR100191446B1
(ko)
*
|
1996-05-02 |
1999-06-15 |
송영욱 |
파클리탁셀 함유 전신성 홍반성 낭창치료제
|
NZ505584A
(en)
|
1996-05-24 |
2002-04-26 |
Univ British Columbia |
Delivery of a therapeutic agent to the smooth muscle cells of a body passageway via an adventia
|
KR100330373B1
(ko)
*
|
1996-05-28 |
2002-11-07 |
주식회사한국신약 |
탁솔을 함유한 주사용 약제 조성물
|
US5877205A
(en)
*
|
1996-06-28 |
1999-03-02 |
Board Of Regents, The University Of Texas System |
Parenteral paclitaxel in a stable non-toxic formulation
|
KR100358934B1
(ko)
*
|
1996-09-13 |
2003-01-29 |
주식회사한국신약 |
탁솔을함유한주사용약제조성물
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
BR9713661A
(pt)
*
|
1996-12-30 |
2000-10-24 |
Battelle Memorial Institute |
Formulação e método para o tratamento de neoplasmas por inalação
|
CN1177934C
(zh)
*
|
1997-04-28 |
2004-12-01 |
阿文蒂斯药物股份有限公司 |
腺病毒介导的肿瘤内投送血管生成拮抗剂用于肿瘤的治疗
|
CN1101677C
(zh)
*
|
1997-05-30 |
2003-02-19 |
韩万愚 |
含有紫杉醇的药用注射溶液
|
ATE226070T1
(de)
*
|
1997-05-30 |
2002-11-15 |
Man Woo Han |
Taxol enthaltende pharmazeutische injektionslösung
|
BE1011216A3
(fr)
*
|
1997-06-13 |
1999-06-01 |
Thissen En Abrege L T B Lab |
Forme pharmaceutique pour l'administration de paclitaxel, procede de preparation d'une composition de paclitaxel prete a l'emploi et utilisation de cette composition.
|
US5925776A
(en)
*
|
1997-12-24 |
1999-07-20 |
Schein Pharmacetical, Inc. |
Polyethoxylated castor oil, process of making the same and formulations thereof
|
GB9803448D0
(en)
*
|
1998-02-18 |
1998-04-15 |
Pharma Mar Sa |
Pharmaceutical formulation
|
US5922754A
(en)
*
|
1998-10-02 |
1999-07-13 |
Abbott Laboratories |
Pharmaceutical compositions containing paclitaxel
|
US6071952A
(en)
*
|
1998-12-02 |
2000-06-06 |
Mylan Pharmaceuticals, Inc. |
Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
EP2266607A3
(en)
|
1999-10-01 |
2011-04-20 |
Immunogen, Inc. |
Immunoconjugates for treating cancer
|
SI1229922T1
(sl)
*
|
1999-11-15 |
2008-04-30 |
Pharma Mar Sa |
Zdravljenje raka z aplidinom
|
JP2003521545A
(ja)
*
|
2000-02-02 |
2003-07-15 |
フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド |
改良された溶解性を有するタキサン製剤
|
KR20010100194A
(ko)
*
|
2000-03-13 |
2001-11-14 |
박호군 |
여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
|
US6919370B2
(en)
*
|
2000-11-28 |
2005-07-19 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
|
CN1555253A
(zh)
*
|
2001-09-13 |
2004-12-15 |
������ѧ�����о�Ժ |
化疗栓塞用紫杉醇的油性组合物、制剂及它们的制造方法
|
EP1435991B1
(en)
*
|
2001-10-19 |
2008-10-15 |
Pharma Mar, S.A. |
Use of aplidine for the treatment of pancreatic cancer
|
US20040092428A1
(en)
*
|
2001-11-27 |
2004-05-13 |
Hongming Chen |
Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
|
AU2003234670B2
(en)
*
|
2002-05-24 |
2010-06-10 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
US8313760B2
(en)
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
EP1534340B1
(en)
|
2002-09-06 |
2011-11-16 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
|
US20080220074A1
(en)
*
|
2002-10-04 |
2008-09-11 |
Elan Corporation Plc |
Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
|
JP2007514472A
(ja)
*
|
2003-11-20 |
2007-06-07 |
アンジオテック インターナショナル アーゲー |
軟組織移植片および瘢痕化抑制剤
|
KR101203475B1
(ko)
*
|
2004-09-22 |
2012-11-21 |
니폰 가야꾸 가부시끼가이샤 |
신규 블록 공중합체, 미셀 제제물 및 이를 유효성분으로함유하는 항암제
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
JP2008543789A
(ja)
|
2005-06-17 |
2008-12-04 |
ホスピラ オーストラリア ピーティーワイ エルティーディー |
ドセタキセルの液体薬学的処方物
|
GB0517092D0
(en)
*
|
2005-08-19 |
2005-09-28 |
Novartis Ag |
New compositions containing taxane derivatives
|
AR054215A1
(es)
*
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
BRPI0600194A
(pt)
|
2006-01-30 |
2007-10-23 |
Quiral Quimica Do Brasil S A |
composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas
|
CN101023940A
(zh)
*
|
2006-02-20 |
2007-08-29 |
郝守祝 |
一种紫杉烷类化合物的药用组合物、制备方法及用途
|
US8323669B2
(en)
|
2006-03-28 |
2012-12-04 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of taxane
|
RU2447095C2
(ru)
|
2006-05-18 |
2012-04-10 |
Ниппон Каяку Кабусики Кайся |
Высокомолекулярный конъюгат подофиллотоксинов
|
JP5548364B2
(ja)
*
|
2006-10-03 |
2014-07-16 |
日本化薬株式会社 |
レゾルシノール誘導体の高分子結合体
|
WO2008056596A1
(en)
|
2006-11-06 |
2008-05-15 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
US8188222B2
(en)
|
2006-11-08 |
2012-05-29 |
Nippon Kayaku Kabushiki Kaisha |
High molecular weight derivative of nucleic acid antimetabolite
|
CA2674788A1
(en)
|
2007-01-08 |
2008-07-17 |
Government Of The Usa, As Represented By The Secretary, Department Of He Alth And Human Services |
Slco1b3 genotype
|
CZ200756A3
(cs)
*
|
2007-01-23 |
2008-07-30 |
Heaton, A. S. |
Dvousložková farmaceutická kompozice obsahující taxan
|
JP2010516625A
(ja)
|
2007-01-24 |
2010-05-20 |
インサート セラピューティクス, インコーポレイテッド |
制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
|
CN101244053B
(zh)
*
|
2007-02-16 |
2010-12-08 |
石药集团中奇制药技术(石家庄)有限公司 |
以多西他赛为主组分的新的分散体系
|
CN102014918A
(zh)
*
|
2007-04-20 |
2011-04-13 |
太阳医药工业有限公司 |
由微量沉淀产生的药学组合物
|
KR20100023862A
(ko)
*
|
2007-06-22 |
2010-03-04 |
싸이도우스 엘엘씨. |
트윈 80을 함유하지 않은 도세탁셀의 용해 제제
|
CN101808651B
(zh)
|
2007-09-28 |
2013-03-27 |
日本化药株式会社 |
类固醇类的高分子结合物
|
CN101396354B
(zh)
*
|
2007-09-30 |
2010-12-01 |
江苏恒瑞医药股份有限公司 |
一种稳定的塔三烷类化合物液体组合物及其制备方法和其应用
|
WO2009047794A2
(en)
*
|
2007-10-01 |
2009-04-16 |
Intas Pharmaceuticals Limited |
Taxane derivative composition
|
AR063111A1
(es)
*
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
JP5694782B2
(ja)
|
2008-03-14 |
2015-04-01 |
バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド |
肺癌、腺癌及び他の病状のための治療方法及び組成物
|
JP5667886B2
(ja)
|
2008-03-14 |
2015-02-12 |
バイオニューメリック・ファーマスーティカルズ・インコーポレイテッド |
癌患者の生存時間を増大させるための組成物及び化合物の使用方法
|
US8920788B2
(en)
*
|
2008-03-18 |
2014-12-30 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of physiologically active substances
|
TWI675668B
(zh)
|
2008-03-18 |
2019-11-01 |
美商建南德克公司 |
抗her2抗體-藥物結合物及化療劑之組合及使用方法
|
US9149540B2
(en)
|
2008-05-08 |
2015-10-06 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of folic acid or folic acid derivative
|
ES2344674B1
(es)
*
|
2008-08-07 |
2011-06-29 |
Gp Pharm, S.A. |
Composicion farmaceutica inyectable de taxanos.
|
EP2331140B1
(en)
|
2008-08-11 |
2018-07-04 |
Nektar Therapeutics |
Multi-arm polymeric alkanoate conjugates
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
MX2011009413A
(es)
|
2009-03-11 |
2011-10-21 |
Ambit Biosciences Corp |
Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer.
|
EP2431403B1
(en)
|
2009-05-15 |
2016-09-28 |
Nipponkayaku Kabushikikaisha |
Polymer conjugate of bioactive substance having hydroxy group
|
US8476310B2
(en)
|
2009-10-19 |
2013-07-02 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US8912228B2
(en)
|
2009-10-19 |
2014-12-16 |
Scidose Llc |
Docetaxel formulations with lipoic acid
|
US20110092579A1
(en)
*
|
2009-10-19 |
2011-04-21 |
Scidose Llc |
Solubilized formulation of docetaxel
|
US7772274B1
(en)
|
2009-10-19 |
2010-08-10 |
Scidose, Llc |
Docetaxel formulations with lipoic acid
|
US8541465B2
(en)
*
|
2009-10-19 |
2013-09-24 |
Scidose, Llc |
Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
|
MY164086A
(en)
|
2009-10-29 |
2017-11-30 |
Aventis Pharma Sa |
Novel antitumoral use of cabazitaxel
|
BR112012012210B8
(pt)
*
|
2009-11-23 |
2021-05-25 |
Cerulean Pharma Inc |
conjugado de (cdp)-taxano de polímero contendo ciclodextrina, composição, composição farmacêutica, forma de dosagem, kit e uso de um conjugado de cdp-taxano
|
TW201129380A
(en)
|
2009-12-04 |
2011-09-01 |
Genentech Inc |
Methods of treating metastatic breast cancer with trastuzumab-MCC-DM1
|
EP2519526B1
(en)
|
2009-12-31 |
2014-03-26 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Tricyclic compounds for use as kinase inhibitors
|
CA2787714C
(en)
|
2010-01-22 |
2019-04-09 |
Joaquin Pastor Fernandez |
Inhibitors of pi3 kinase
|
JP2013519719A
(ja)
|
2010-02-18 |
2013-05-30 |
セントロ ナシオナル デ インベスティガシオネス オンコロヒカス(セエネイオ) |
トリアゾロ[4,5−b]ピリジン誘導体
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
WO2011121317A1
(en)
|
2010-04-01 |
2011-10-06 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Imidazo [2,1-b] [1,3,4] thiadiazoles as protein or lipid kinase inhibitors
|
CA2798180A1
(en)
|
2010-05-03 |
2011-11-10 |
Teikoku Pharma Usa, Inc. |
Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
|
WO2012052745A1
(en)
|
2010-10-21 |
2012-04-26 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Combinations of pi3k inhibitors with a second anti -tumor agent
|
CA2816997A1
(en)
|
2010-11-17 |
2012-05-24 |
Nippon Kayaku Kabushiki Kaisha |
Novel polymer derivative of cytidine metabolic antagonist
|
WO2012088445A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
|
WO2012088422A1
(en)
|
2010-12-22 |
2012-06-28 |
Nektar Therapeutics |
Multi-arm polymeric prodrug conjugates of taxane-based compounds
|
CN103857395A
(zh)
|
2011-04-01 |
2014-06-11 |
基因泰克公司 |
Akt抑制剂化合物和阿比特龙的组合及使用方法
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
ES2907071T3
(es)
|
2011-05-19 |
2022-04-21 |
Fundacion Del Sector Publico Estatal Centro Nac De Investigaciones Oncologicas Carlos Iii F S P Cnio |
Compuestos macrocíclicos como inhibidores de proteína quinasas
|
WO2012156999A1
(en)
|
2011-05-19 |
2012-11-22 |
Manu Chaudhary |
Ready to use docetaxel formulation
|
WO2013005057A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
New compounds
|
WO2013005041A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Tricyclic heterocyclic compounds as kinase inhibitors
|
WO2013004984A1
(en)
|
2011-07-07 |
2013-01-10 |
Centro Nacional De Investigaciones Oncologicas (Cnio) |
Tricyclic compounds for use as kinase inhibitors
|
SI2753355T1
(sl)
|
2011-09-08 |
2019-02-28 |
New York University |
Onkolitični virus herpesa simpleksa in njegove terapevtske uporabe
|
CA2847114C
(en)
|
2011-09-11 |
2018-08-21 |
Nippon Kayaku Kabushiki Kaisha |
Method for manufacturing block copolymer
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
WO2013177426A2
(en)
|
2012-05-24 |
2013-11-28 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
|
AU2013273489B9
(en)
|
2012-06-08 |
2018-08-23 |
F. Hoffmann-La Roche Ag |
Mutant selectivity and combinations of a phosphoinositide 3 Kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
WO2014055493A1
(en)
|
2012-10-02 |
2014-04-10 |
Cerulean Pharma Inc. |
Methods and systems for polymer precipitation and generation of particles
|
US10238723B2
(en)
|
2013-03-14 |
2019-03-26 |
Icahn School Of Medicine At Mount Sinai |
Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
|
WO2015050844A1
(en)
|
2013-10-01 |
2015-04-09 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
CN110841074B
(zh)
|
2014-03-21 |
2023-07-18 |
艾伯维公司 |
抗-egfr抗体及抗体药物偶联物
|
US10350264B2
(en)
|
2014-03-27 |
2019-07-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
WO2016205429A1
(en)
|
2015-06-15 |
2016-12-22 |
New York University |
Method of treatment using oncolytic viruses
|
US10188626B2
(en)
|
2015-11-03 |
2019-01-29 |
Cipla Limited |
Stabilized cabazitaxel formulations
|
SG10201914119TA
(en)
|
2016-06-08 |
2020-02-27 |
Abbvie Inc |
Anti-b7-h3 antibodies and antibody drug conjugates
|
CA3027033A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
US20200002421A1
(en)
|
2016-06-08 |
2020-01-02 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
JP2019522643A
(ja)
|
2016-06-08 |
2019-08-15 |
アッヴィ・インコーポレイテッド |
抗cd98抗体及び抗体薬物コンジュゲート
|
CA3027103A1
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
WO2019047812A1
(zh)
|
2017-09-07 |
2019-03-14 |
深圳信立泰药业股份有限公司 |
多西他赛共缀物的药物组合物及制备方法
|
UY39610A
(es)
|
2021-01-20 |
2022-08-31 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|